Search hospitals > Ohio > Troy
Upper Valley Medical Center
Claim this profileTroy, Ohio 45373
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
272 reported clinical trials
4 medical researchers
Summary
Upper Valley Medical Center is a medical facility located in Troy, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Upper Valley Medical Center is involved with conducting 272 clinical trials across 440 conditions. There are 4 research doctors associated with this hospital, such as Howard M. Gross, Tarek M. Sabagh, Michael Guy, MD, and Jhansi L. Koduri.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Howard M. GrossDayton Physician LLC-Miami Valley Hospital North4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
128 reported clinical trials
194 drugs studied
Tarek M. SabaghMiami Valley Hospital South4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
67 reported clinical trials
123 drugs studied
Michael Guy, MDMiami Valley Hospital South1 year of reported clinical research
Studies Cancer
Studies Ovarian Cancer
17 reported clinical trials
45 drugs studied
Jhansi L. KoduriMiami Valley Hospital South1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
19 drugs studied
Clinical Trials running at Upper Valley Medical Center
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Squamous Cell Carcinoma
Bladder Cancer
Renal Cell Carcinoma
Bladder Carcinoma
Esophageal Cancer
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Upper Valley Medical Center?
Upper Valley Medical Center is a medical facility located in Troy, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Upper Valley Medical Center is involved with conducting 272 clinical trials across 440 conditions. There are 4 research doctors associated with this hospital, such as Howard M. Gross, Tarek M. Sabagh, Michael Guy, MD, and Jhansi L. Koduri.